✦ LIBER ✦

Down-regulation of fragile histidine triad expression in prostate carcinoma

✍ Scribed by Rebecca L. Fouts; George E. Sandusky; Shaobo Zhang; George J. Eckert; Michael O. Koch; Thomas M. Ulbright; John N. Eble; Liang Cheng

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 303 KB
Volume: 97
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.11201

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

The fragile histidine triad (fhit) gene is a tumor suppressor gene that belongs to the histidine triad family of nucleoside binding proteins. the gene encompasses the common human chromosomal fragile site, the fra3b locus at chromosome 3p14.2, and is expressed in most normal adult tissues and tumor cell lines. numerous studies have indicated that the fhit gene on chromosome 3p may play an important role in human neoplasia, although very few studies have investigated the fhit gene in prostate carcinoma.

Methods:

Using immunohistochemical analyses, the authors studied the expression of fhit in prostate tumors from 84 radical prostatectomy specimens to determine whether there were any correlations between fhit expression and various clinicopathologic characteristics.

Results:

The percentages of cells stained with antibody to fhit were significantly lower overall for tumor cells compared with normal cells (p = 0.0001). fhit immunostaining intensity also was significantly lower for tumor cells compared with normal cells (p = 0.0001). a weak but statistically significant correlation (p = 0.045) was demonstrated with the presence of extraprostatic extension in the patient samples. no other significant correlation was seen between the percentage of cells stained for fhit or fhit immunostaining intensity and gleason grade, tumor stage, tumor size, lymph node metastasis, surgical margins, vascular invasion, perineural invasion, or the presence of high-grade prostatic intraepithelial neoplasia.

Conclusions:

The data presented indicate a down-regulation of the fhit tumor suppressor gene in prostate carcinoma and, thus, propose a potential target for therapeutic intervention.

📜 SIMILAR VOLUMES

Fragile histidine triad gene expression

Fragile histidine triad gene expression in primary prostate cancer and in an in vitro model

✍ Guo, Zongyou; Johansson, Sonny L.; Rhim, Johng S.; Vishwanatha, Jamboor K. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 610 KB

## BACKGROUND. The fragile histidine triad (FHIT) is frequently deleted and altered in many human cancers. Replacement of the FHIT gene into cancer cell lines lacking FHIT expression results in loss of tumorigenicity and tumor growth. METHODS. We investigated the status and function of the FHIT gen

Fragile histidine triad transcription ab

Fragile histidine triad transcription abnormalities and human papillomavirus E6–E7 mRNA expression in the development of cervical carcinoma

✍ Tomoya Segawa; Toshiyuki Sasagawa; Hiroshi Yamazaki; Jun Sakaike; Hiroshi Ishika 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 627 KB

## BACKGROUND. Human papillomaviruses (HPV) are the most important etiologic factor for cervical carcinoma. However, additional cellular events may be necessary for malignant progression in the cervix. Recently, the fragile histidine triad (FHIT) gene, which is frequently lost in many cancers, was

Analysis of the fragile histidine triad

Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines

✍ Gen Tamura; Ken Sakata; Satoshi Nishizuka; Chihaya Maesawa; Yasushi Suzuki; Take 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

The FHIT (fragile histidine triad) gene has been isolated from the chromosome region 3p14.2, which includes the fragile site locus FRA3B and the breakpoint of the t(3;8) of familial renal carcinoma. FHIT has been suggested to be a candidate tumor suppressor gene for digestive tract carcinomas. To ev

Expression of p27/kip1 is down-regulated

Expression of p27/kip1 is down-regulated in human prostate carcinoma progression

✍ Fern�ndez, Pedro L.; Arce, Yolanda; Farr�, Xavier; Mart�nez, Antonio; Nadal, Alf 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 2 views

p27 Kip1 is a cyclin-dependent kinase inhibitor whose down-regulation has been observed in several tumour models, including breast, colorectal, and gastric carcinomas. The purpose of this study was to assess p27 Kip1 protein expression in normal and benign prostatic epithelia as well as the possible

Down-regulation of CD44 expression in hu

Down-regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation

✍ Nicole S. Verkaik; Jan Trapman; Johannes C. Romijn; Theodorus H. Van der Kwast; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 128 KB 👁 2 views

Down-regulation of the cell-surface adhesion molecule CD44 has been suggested to play an important role in tumor progression and metastasis of prostate cancer. CD44 is encoded by a gene that contains a CpG-rich region (CpG island) in its 5Ј regulatory sequence. We tried to assess whether hypermethyl

The methylation status and protein expre

The methylation status and protein expression of CDH1, p16INK4A, and fragile histidine triad in nonsmall cell lung carcinoma : Epigenetic silencing, clinical features, and prognostic significance

✍ Shoji Nakata; Kenji Sugio; Hidetaka Uramoto; Tsunehiro Oyama; Takeshi Hanagiri; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views